Ao Sun

Nanjing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

MTFR2 promotes VDAC1 oligomerization to reprogram BCAA metabolism in tumor cells to polarize TAMs in LUAD.

MTFR2 promotes VDAC1 oligomerization to reprogram BCAA metabolism in tumor cells to polarize TAMs in LUAD.

Journal: Cell death & disease
Published: December 02, 2025

Cadonilimab (PD-1/CTLA-4 bispecific antibody) combination therapy for driver gene-negative advanced NSCLC: a single-center retrospective real-world study.

Cadonilimab (PD-1/CTLA-4 bispecific antibody) combination therapy for driver gene-negative advanced NSCLC: a single-center retrospective real-world study.

Journal: Frontiers in oncology
Published: October 03, 2025

Identification of mitochondrial-related genes to evaluate the immune infiltration and prognosis of lung adenocarcinoma.

Identification of mitochondrial-related genes to evaluate the immune infiltration and prognosis of lung adenocarcinoma.

Journal: PeerJ
Published: April 23, 2025

First-Line Pyrotinib Combination Therapy for HER2-Mutated Advanced NSCLC: A Retrospective Cohort Analysis.

First-Line Pyrotinib Combination Therapy for HER2-Mutated Advanced NSCLC: A Retrospective Cohort Analysis.

Journal: Current oncology (Toronto, Ont.)
Published: January 12, 2025

CCT6A facilitates lung adenocarcinoma progression and glycolysis via STAT1/HK2 axis.

CCT6A facilitates lung adenocarcinoma progression and glycolysis via STAT1/HK2 axis.

Journal: Journal of translational medicine
Published: January 28, 2024

Advances in the Diagnosis and Treatment of Advanced Non-Small-Cell Lung Cancer With EGFR Exon 20 Insertion Mutation.

Advances in the Diagnosis and Treatment of Advanced Non-Small-Cell Lung Cancer With EGFR Exon 20 Insertion Mutation.

Journal: Clinical lung cancer
Published: September 24, 2023

Establishment of prognostic risk model and drug sensitivity based on prognostic related genes of esophageal cancer.

Establishment of prognostic risk model and drug sensitivity based on prognostic related genes of esophageal cancer.

Journal: Scientific reports
Published: October 07, 2021

UCHL1 acts as a potential oncogene and affects sensitivity of common anti-tumor drugs in lung adenocarcinoma.

UCHL1 acts as a potential oncogene and affects sensitivity of common anti-tumor drugs in lung adenocarcinoma.

Journal: World journal of surgical oncology
Published: October 06, 2021
Showing 1-8 of 8

Last Updated: 09/26/2026